Riskpilot← Back to searchSign inGet full accessFrauenfeld Holding AB
ABActiveOrg 5592042229Economic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
+8% vs 2023
Equity ratio
99.1%
Financial strength
Net profit 2024
SEK -3K
-18% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -15K | +8% |
| Net profit | SEK -3K | -18% |
| Total assets | SEK 1,6M | +0% |
| Equity | SEK 1,6M | +0% |
| Employees | 0 | — |
Legal name
Frauenfeld Holding AB
Org number
5592042229
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
2 maj 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall äga och förvalta fast och lös egendom, bedriva konsulttjänster inom bioteknik, medicin och management samt därmed förenlig verksamhet.
Address
Email
jens.frauenfeld@salipro.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −23 | −13 | −22 | −16 | −15 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −23 | −13 | −22 | −16 | −15 |
| Net financials | — | — | 1 | 13 | 12 |
| Profit before tax | −23 | −13 | −21 | −3 | −3 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −23 | −13 | −21 | −3 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 643 | 1 630 | 1 617 | 1 614 | 1 610 |
| Equity | 1 635 | 1 622 | 1 602 | 1 599 | 1 595 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 8 | 8 | 15 | 15 | 15 |
| Total debt | 8 | 8 | 15 | 15 | 15 |
EBITDA margin
-1505200.0%
This company
15.8%
Market median
-9526682% vs market
20202024
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20202024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20202024
Net profit margin
-343700.0%
This company
8.1%
Market median
-4243310% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JF Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Frauenfeld Holding AB 
Salipro Biotech ABBoard members of Frauenfeld Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Frauenfeld | Chief Executive Officer | 0 companies |
| Christine Becker | Deputy Board Member | 0 companies |